By Staff
Thursday, September 12, 2024 11:40 AM
After events in Rome and Bari, Vision Defense Commission ETS will participate in the Race for the Cure 2024 in Bologna, providing free vision checks in collaboration with AMOA ETS – Association of Ophthalmologists for Africa and Federottica Bologna.
By Staff
Wednesday, September 11, 2024 2:13 PM
From September 20 to 23, inspired by the Olympic values of performance, innovation and talent, Silmo Paris opens its doors to all industry professionals. With more than 900 exhibitors and 1,500 brands, this year’s event promises to be an experience where the exchange of ideas, the discovery of the latest trends, forecasts, training and information are at the heart of the interactions.
By Staff
Tuesday, September 10, 2024 9:05 AM
Davide Degl’Incerti Tocci, current ANFAO vice president responsible for the Gruppo Giovani, digitization and internationalization, as well as CEO of Nannini Italian Quality, is the new president of DaTE, the eyewear event focused on the avantgarde and innovation, set to take place September 13-15, 2025.
By Staff
Monday, September 9, 2024 12:17 PM
Following the success of the 2023 edition, Opto-Réseau has reinforced its position as a founding partner of the Summer School in Entrepreneurship, in collaboration with the University of Montreal’s School of Optometry and Millénium Québecor. Thanks to this partnership, a training program was deployed on August 28 and 29 to instill an entrepreneurial spirit in 4th- and 5th-year optometry students.
By Staff
Friday, September 6, 2024 3:14 PM
Nikon Optical Canada announces the appointment of Denise Bernachez as the company’s new president, effective September 1, 2024. This appointment marks an important milestone for Nikon Optical Canada, reflecting their commitment to innovation, diversity and community involvement.
By Staff
Thursday, September 5, 2024 11:31 AM
EssilorLuxottica (rated A2 stable by Moody’s and A stable by S&P) successfully launched a bond issuance for a total amount of €2 billion with tenors of 4.5 and 7.5 years, carrying respectively a coupon of 2.875 percent and 3.00 percent (the "Bonds") with an average rate after hedging of 2.99 percent.
By Staff
Wednesday, September 4, 2024 2:41 PM
ViGeneron in Munich, Germany has launched a new Phase 1b clinical trial testing a novel gene replacement therapy in individuals affected by retinitis pigmentosa (RP) caused by mutations in the CNGA1 gene. This new therapy can be injected into the vitreous. Injections such as these are frequently done in an ophthalmologist’s office and do not require more advanced surgery.
By Staff
Tuesday, September 3, 2024 7:00 AM
In the bustling environment of an optometry clinic, dealing with children can present unique challenges. From apprehension about eye exams to fear of the unknown, children often experience heightened emotions during their clinic visits. Therefore, fostering emotional intelligence among optometry clinic staff is paramount in creating a supportive and comforting atmosphere for young patients.
By Staff
Friday, August 30, 2024 9:00 AM
CooperVision Canada announces its 2024 consumer myopia control advocacy initiative, “Your Child’s Tomorrow Starts Today.” This year’s initiative focuses on the critical importance of scheduling comprehensive eye exams for children before the school year begins, educating parents and caregivers about the consequences of myopia, and MiSight 1 day’s ability to slow its progression and keep it from getting worse.
By Staff
Thursday, August 29, 2024 10:37 AM
Former professional football referee and current television rules analyst Gene Steratore is teaming with the Contact Lens Institute (CLI) to promote healthy contact lens wear and care. In a new video timed to the start of football season, the well-known broadcaster encourages eyecare professionals to use The EASY Way when speaking with soft contact lens patients.
By Staff
Wednesday, August 28, 2024 2:40 PM
In response to the rising visibility of beauty trends on the internet and social media, the Centre for Ocular Research & Education (CORE) has dedicated Issue 79 of
Contact Lens Update to the effect of cosmetics and cosmetic treatments on the eye.
By Staff
Tuesday, August 27, 2024 1:37 PM
ZUG, Switzerland—Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company, has announced the appointment of Sharon Klier, MD, MS, MPH, an executive leader with extensive experience in clinical development across early and late-stage programs, regulatory submissions and approvals, to the role of chief development officer.
By Staff
Monday, August 26, 2024 10:42 AM
This autumn, CooperVision will deliver a 12-date UK and Ireland myopia management tour. The evening events will include discussion workshops hosted by CooperVision’s Professional Affairs team, highlighting the importance of communication and how every member of the practice team can play their part in increasing awareness of myopia and access to the interventions available to slow its worsening.
By Staff
Friday, August 23, 2024 9:05 AM
SHANGHAI—OcuMension Therapeutics, a leading Chinese ophthalmic pharmaceutical platform company, has announced an agreement with Alcon Inc., a leader in eyecare, in which OcuMension has acquired commercialization rights in China to a portfolio of Alcon dry eye treatments and procedural drops, including several commercially available products and one development-stage product.
By Staff
Thursday, August 22, 2024 12:00 PM
NUREMBERG—Eschenbach Optik and Tom Tailor announce that they have agreed to jointly launch a new licensed brand, TOM TAILOR Eyewear. Planned for August 2025, the TOM TAILOR Eyewear brand will present a collection of sun and optical styles that echo the Hamburg-based fashion brand’s timeless, casual aesthetic, according to the companies.